Search Submit Your Manuscript

Become A Member

  1. Home
  2. April 2023
  3. 21. Efficacy of GeneXpert in Active Case Detection Among Contacts of Drug Resistant TB Patients
Article Image
Admin

21. Efficacy of GeneXpert in Active Case Detection Among Contacts of Drug Resistant TB Patients

Sami Ahmad1, Javed Iqbal1, Saleha Zafar3, Jaweria Aslam2, Hamnah Zahid2 and
Wajih ur Rahman2

ABSTRACT

Objective: This study was undertaken to see the value of GeneXpert MTB Rif Assay in diagnosing the TB among suspicious household contacts and its incremental yield over smear microscopy and x-ray.

Study Design: Descriptive study

Place and Duration of Study: This study was conducted at the Department of Pulmonology, Bahawal Victoria Hospital, Bahawalpur from January 2017 to December 2022.

Materials and Methods: Systemic tool for active TB case detection was followed as devised by WHO that proposes an interview about symptoms of TB. Suspects were asked to submit a spot sputum specimen for ZN smear and GeneXpert MTB Rif Assay simultaneously at the time chest radiograph.

Results: A total of 545 index drug resistant TB patients were included for contact screening. A total of 2754 contacts with mean of 5.36±2.75 were verbally screened for tuberculosis using Baseline individual risk assessment questionnaire and a total 945 contacts were assessed for further investigation. Findings of x-ray suggesting any change in lungs of 7.1% contacts, smear positivity was found in 6.3% and GeneXpert MTB Rif Assay detected 9.8% of which 45.2% contacts were resistant to rifampicin.

Conclusion: Active case detection of contacts is important in high burden settings while modern GeneXpert is a great addition in diagnostic tools and equally valuable in detection of TB among contacts and showed higher yield of MTB case detection as 37.6% over smear microscopy and 39.8% over X-ray.

Key Words: GeneXpert, Tuberculosis, Diagnosis, Drug Resistance.

Citation of article: Ahmad S, Iqbal J, Zafar S, Aslam J, Zahid H, Rahman W. Efficacy of GeneXpert in Active Case Detection Among Contacts of Drug Resistant TB Patients. Med Forum 2023;34(4):80-84.